Biotech Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma
Asthma control can be maintained with a step down daily dose of fluticasone propionate/salmeterol
May 18th, 2006
In patients who have controlled their asthma with fluticasone propionate/salmeterol (FSC) 250/50 microg twice daily, stepping treatment down to a lower dose of FSC 100/50 microg twice daily is more effective than switching to an inhaled corticosteroid alone. According to recent research from England, "Asthma control is the goal of treatment, but little data exist to support treatment strategies for stepping down treatment once control has been achieved. We assessed whether either the long-acting beta2 -agonist or corticosteroid could be reduced without loss of asthma control once control had been attained with FSC. After 12 weeks of open-label treatment with...
Source: Biotech Business Week (2006-05-18)
|
